ReviewTherapeutic advances in musculoskeletal disease2023

Anti-sclerostin antibodies: a new frontier in fragility fractures treatment.

Giovanni Iolascon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.